Pneumonia vaccine for all
Pneumonia vaccine for all
The high mortality rate in children under the age of five years might soon be a thing of the past. This follows the announcement by the Department of Health that it will roll-out Prevenar, a vaccine that prevents pneumococcus pneumonia, one of the leading causes of child deaths.
The Department of Health has announced that the vaccine, which was only available in private hospitals at a high cost of R1600, will soon be available in public hospitals.
‘This is one of the most important announcements this year made in relation to health’¦ that they are introducing this vaccine to become part of the routine immunization program. And we hope that we will be able to then show the immense benefit that this vaccine will have in preventing death in children less than five years of age,’ said Dr Anne von Gottberg, a Clinical Microbiologist at the National Institute for Communicable Diseases.
South Africa has made no progress in reducing the child mortality rate in the past 18 years, according to the 2008 Lancet report, a respected British medical journal. It says the country’s child mortality rate had risen from 60 to 69 deaths per 1000 live births between 1990 and 2006. The report singles out HIV and AIDS as being responsible for 57 percent of child deaths.
Pneumonia is one of the opportunistic infections associated with HIV infection. Dr von Gottberg added that the availability of the vaccine in the public sector ‘will prevent a lot of the opportunistic infections that are related to HIV/AIDS children. Streptococcus pneumonia is one of the most important bacterial opportunistic infections that are found in children with HIV,’ she said.
The vaccine will be first made available in the Eastern Cape later this year, and will then be rolled out nationally early next year. Dr von Gottberg says there is also a plan in place to accommodate those babies and children who might, for a number of reasons, miss the vaccine.
‘If the children miss these visits or as they are older, because when this vaccine is introduced some children will be old to be eligible for these visits, there will be also a catch-up campaign where older children will also be eligible to receive the vaccine,’ she said.
The vaccine was first introduced in 2005. But it was only available in private hospitals at an exorbitant cost of R1600. Dr David Bloom, Manager of Global Health Studies at Harvard University in the US, says expenditure on making the childhood vaccine available in the public health sector should be viewed as a positive step forward.
‘Spending on childhood vaccination programs does a lot more than just reduce morbidity and mortality. It also promotes national economic growth and poverty reduction – both of which are crucial issues here in South Africa,’ said Dr Bloom.The vaccine is regarded as highly effective in preventing pneumococcus pneumonia, which according to the 2006 report of the United Nations’ Children Fund (UNICEF), kills two million children worldwide every year.
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
View all posts
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Pneumonia vaccine for all
by Health-e News, Health-e News
August 27, 2008